Inovio Pharmaceuticals (INO) surged 213.7% to $1.89 on FDA approval of its first product, INO-3107 (Voceryq). Jefferies upgraded the stock to Buy from Hold with a $3.00 price target, raising it from $1.80. H.C. Wainwright reiterated Neutral at $2.50. The stock retreated to $1.215 by Friday, down 36% from Monday's close.
Goldman Sachs upgraded Ibotta (IBTA) to Neutral from Sell and raised its price target to $58 from $35. The stock closed at $60.35, up 20.5% from $50.07. Goldman cited traction in the platform transition following Q3 results.
Amdocs (DOX) fell 30.1% to $43.66 after Oppenheimer downgraded the stock. The company guided fiscal 2027 revenue and profit sharply lower due to a dispute with T-Mobile. Q4 results met expectations, so the guidance drove the decline.
NerdWallet (NRDS) dropped 31.0% to $7.89 after William Blair cut the stock to Market Perform. Q3 earnings missed expectations with EPS of $0.23 versus $0.34 forecast and revenue of $239.6M against $251.89M expected. The stock fell another 12.1% Friday to $5.24.
ADTRAN (ADTN) fell 19.4% to $5.06 after Rosenblatt downgraded on telco exposure. LegalZoom (LZ) declined 13.7% to $5.955 after BofA downgraded and cut its target to $6. Floor & Decor (FND) rose 3.3% to $49.14 despite a Goldman Sachs downgrade to Sell.
Friday's largest gains included Sylvamo (SLVM) at plus 19.1%, Centrus Energy (LEU) at plus 17.5% on a Roth/MKM upgrade, and SiTime (SITM) at plus 17.4% on a Seaport upgrade.